key: cord-0882496-uz8q3gxr
authors: Chen, Yale Tung; de Gracia, Milagros Martí; Díez-Tascón, Aurea; Alonso-González, Rodrigo; Rodríguez-Fuertes, Pablo; Parra-Gordo, Maria Luz; Ossaba-Vélez, Silvia; Agudo-Fernández, Sergio; Fuertes, Rafael Llamas
title: CORRELATION BETWEEN CHEST COMPUTED TOMOGRAPHY AND LUNG ULTRASONOGRAPHY IN PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19)
date: 2020-07-13
journal: Ultrasound Med Biol
DOI: 10.1016/j.ultrasmedbio.2020.07.003
sha: 8c48ecfd0686f5e0d2795bf915eba60d0355b095
doc_id: 882496
cord_uid: uz8q3gxr

There is growing evidence regarding the imaging findings of Coronavirus Disease 2019 (COVID-19), in chest X-ray and Computed Tomography scan (CT). At this moment, the role of Lung Ultrasonography (LUS) has yet to be explored. The main purpose of this study is to evaluate the correlation between LUS findings and chest CT in confirmed (positive RT-PCR) or clinically highly suspicious (dyspnea, fever, myasthenia, gastrointestinal symptoms, dry cough, ageusia or anosmia) of COVID-19 patients. This prospective study was carried out in the emergency department (ED), confirmed or clinically highly suspicious COVID-19 patients were recruited and were subjected to a chest CT and concurrent LUS exam. An experienced ED physician performed the LUS exam blind to the clinical history and results of the CT scan, which were reviewed by two radiologists in consensus for signs compatible with COVID-19 (bilateral ground-glass opacities in peripheral distribution). Compatible LUS exam was considered a bilateral pattern of B-lines, irregular pleural line and subpleural consolidations. Between March and April 2020, fifty-one patients were consecutively enrolled. The indication for CT was a negative or indeterminate RT-PCR test (49.0%) followed by suspicion of pulmonary embolism (41.2%). Radiological signs compatible with COVID-19 were present in thirty-seven patients (72.5%) on CT scan and forty patients (78.4%) on LUS exam. The presence of LUS findings was correlated with a positive CT scan suggestive of COVID-19 (OR: 13.3, 95%CI: 4.5-39.6, p<0.001) with a sensitivity of 100.0% and a specificity of 78.6%, positive predictive value of 92.5% and negative of 100.0%. There was no missed diagnosis of COVID-19 with LUS compared to CT in our cohort. The LUS Score had a good correlation with CT total severity score (ICC 0.803, 95% CI 0.60-0.90, p<0.001). LUS presents similar accuracy compared to chest CT to detect lung abnormalities in COVID-19 patients.

could be considered enough to sustain author consideration. I suggest to adopt the CT classification recently proposed by Robba C. et al. (pir Physiol Neurobiol 2020 May 10; 103455. doi: 10.1016 /j.resp.2020 instead of describe all CT patterns and than to correlate it to LUS score.

Response: We thank the reviewer for the comment.  "Chest CT features differ among patients, being possible to establish distinct phenotypes that might guide therapy and ventilator settings (Robba et al 2020) . In phenotype 1, a high pulmonary compliance and severe hypoxemia occurs, these patients may benefit from use of low to moderate PEEP and are likely to respond well to inhaled nitric oxide. In phenotype 2, moderate to high PEEP as well as prone positioning may help recruit collapsed areas. Phenotype 3 resembles typical ARDS and should be managed as such. In our study, we found that a cut-off Lung score of 9.5 had a high sensitivity and specificity for detecting phenotype 2". My major concern about the current study and LUS in general is related to the really poor specificity of LUS findings making this method quite useful in the acute phase of the epidemic were the prevalence of COVID-19 is high in hospital phenotypes (N=37) Phenotype 1 -(%) 24 (47.1)

Phenotype 2 -(%) 12 (23.5)

Phenotype 3 -(%) 1 (2) population but that reduces a lot its utility in general population when the prevalence it lowers. I suggest to include this point in discussion.

Response: We thank the reviewer for this helpful comment. We added as a limitation: "The main limitation is that LUS in general has poor specificity, its findings overlap with those from other pneumonia etiologies or incidental chronic findings (e.g., chronic heart failure or pulmonary fibrosis). In epidemic areas, however, positive LUS features, even with negative RT-PCR or chest Xray, can still be highly Reviewer #2:

Potentially Important paper, but some points need to be improved, particularly the results

I don't understand very well the presentation of results.

In particular, -the authors did not perform a proper comparison between CT and LUS. First of all , table 1 and 2 are merely descriptive, while the authors should   provide a further table providing clarify as a limit the lack of correlation with outcomes Response: We thank the reviewer for the comment. We added to discussion the following limitation: "We did not correlate the LUS or CT findings with the patient's outcomes. Moreover, the study was not powered to evaluate the performance of a diagnostic strategy based on LUS exam" In this emergency, is critical the ability to quickly confirm and characterize a 67 suspected case, moreover as almost any emergency department (ED) will struggle to 68 keep up with the increasing number of patients and the shortage of health resources. 69

The main diagnostic method is the reverse transcription polymerase chain reaction 70 (RT-PCR) of the nucleic acid of SARS-CoV-2 has many limitations such as the low 71 sensitivity or the technical difficulties to perform it (Ai et al. 2020) . 72

There is growing evidence regarding the imaging findings of COVID-19. The 73 most common form of radiographic presentation is the presence of a local or bilateral 74 patchy shadowing infiltrate on chest X-ray, although with low sensitivity (absent in 75 more than 40% of the cases) (Guan et al. 2020) . CT scan shows with higher 76 sensitivity ground glass opacities (GGO) (Shi et al. 2020) , being the reason why it has 77 been proposed as the main imaging test, incorporated in different therapeutic and 78 triage strategies since the outbreak started . 79

The use of chest CT remains very limited due to some notable drawbacks. For 80 mild illness, radiation exposure and overuse of health care resources, or lack thereof 81 ability to get a CT scan seems to overshadow the need. In the critically ill, the 82 transport of unstable patients and exposure of infected patients may also outweigh the 83 clinical benefit. Therefore, we need alternative modalities to quickly characterize our 84

Ultrasound machines are widely available and therefore Lung 86 Ultrasonography (LUS) can be performed in few minutes, in mild or even unstable 87 patients, at different hospital settings (American College of Emergency Physicians. 88 2017). Although there is an ongoing debate about how it should be applied, there is a 89 general consensus about its usefulness (Walter et al. 2020 and Kruser et al. 2020 ). In 90 this pandemic, the usefulness of LUS has been suggested on small case reports 91 Soldati et al. 2020) . The presence of subpleural 92 consolidations, irregular pleural line and B-lines are highly suggestive for COVID-19 93 pneumonia (Kruser et al. 2020 and Li et al. 2020) . 94

In this Global Public Health Emergency, the evidence about the role of this 95 technique with comparison to chest CT is limited, and needs to be further defined, in 96 order to minimize the infectious risks. Patients admitted to the ED with RT-PCR proven COVID-19, negative or 108 indeterminate RT-PCR but clinically highly suspicious COVID-19 (dyspnea, fever, 109 myasthenia, gastrointestinal symptoms, dry cough, ageusia or anosmia) that required a 110 chest CT for evaluation. 111

The main indication for CT was a negative or indeterminate RT-PCR but 112 clinically highly suspicious of COVID-19 or suspicion of pulmonary embolism (PE). 113

We excluded patients <18 years or who refused to participate. A convenience 114 sample of fifty-one patients who met these inclusion criteria were consecutively 115 enrolled and prospectively studied. We considered a compatible COVID-19 pneumonia if multilobar or patchy GGO, 158 with or without interlobular septal thickening (crazy paving) or consolidation was 159 present.

We also classified the chest CT patterns according to three main phenotypes that 161 has been recently proposed (Robba et al 2020) : 162 1) multiple, focal, possibly overperfused ground-glass opacities, 163

2) inhomogeneously distributed atelectasis and peribronchial opacities, 164

3) a patchy, ARDS-like pattern. 165

Whenever a chest X-ray was available and performed during the episode was 166 recorded and analyzed. The examinations were performed using a Butterfly IQ (Butterfly Network, 187 Guilford, CT, USA), a hand-held ultrasound system fitted with a curvilinear array 188 transducer (1.5-4.5 MHz) and lung preset. 189

The physician was blinded to the patient past medical history, vital signs, 190 symptoms, laboratory measurements and CT scan result. 191 192

The main purpose of this study is to evaluate the correlation between LUS 194 findings and chest CT in COVID-19 patients (Figure 2 and 3) . 195

We defined a confirmed case any patient with positive and 196 clinically highly suspicious, any patient with dyspnea, fever, myasthenia, 197 gastrointestinal symptoms, dry cough, ageusia or anosmia but negative RT-PCR. The correlations between continuous variables were tested using Spearman's 212 rho test for categorical variables. The sample size for correlation was calculated to 213 detect a 20% of difference between LUS and CT findings, assuming a 95% 214 confidence interval (CI) and power of 80%. 215

Mean values were reported along with 95% confidence intervals. Statistical 216 significance was set at p value < 0.05. 217

Statistical analyses were conducted with IBM SPSS software v20.0 (SPSS 218

Inc., Chicago, IL, USA). 219 220 221

Fifty-one patients were consecutively enrolled between March and April 2020 223 (summarized in Table 1 ). The mean age was 61.4 years (Standard Deviation -SD 224 17.7). At the end of the first week follow-up, 34 patients were admitted to the hospital 225 (66.7%), 4 were admitted to an intensive care unit (ICU, 7.8%), 6 patients had died 226 (11.8%) and 17 were discharged to home (33.3%). 227

Approximately half of the patients (54.9%) had a chest X-ray, in whom 33.2% 228 were normal (table 2) . Ground-glass opacities (GGO) were present in 37 patients 229 (72.5%), with peripheral or diffuse involvement, followed by septal thickening (18 230 patients, 35.2%). There were two patients with only central involvement on CT, one 231 patient had a mild cardiac failure and another patient had viral bronchiolitis. 232

The most common finding and affected zones on LUS were subpleural 233 consolidations on the posterior lower lobes (table 2). The mean LUS score was 10.6 234 (SD 8.4). The mean CT TSS was 7.48 (SD 6.32). The LUS Score had a good 235 correlation with CT TSS (Intraclass Correlation Coefficient -ICC 0.803, 95% 236

Confidence Interval -CI 0.601-0.903, p < 0.001). The severity of lung lesions (Lu et 237 al. 2020) in patients with COVID-19 evaluated by LUS and CT is shown in Table 3 . 238

The age showed a moderate correlation to LUS Score (rho = 0.486; p < 0.001) 239

but not with CT TSS (p = 0.247). Oxygen saturation (SO2) correlated stronger to LUS 240 Score (rho = -0.553; p < 0.001) than to CT TSS (rho = -0.360; p = 0.043). Respiratory 241 rate correlated stronger to LUS Score (rho = 0.529; p < 0.001) than to CT TSS (rho = 242 0.429; p = 0.020). As well, inflammatory markers such as C-reactive protein (CRP) 243 correlated better with LUS Score (rho = 0.600; p = 0.004) than to CT TSS (rho = 244 0.479; p = 0.005). 245

Radiological signs suggestive or highly compatible with COVID-19 were 246 present in thirty-seven patients (72.5%) on CT scan and forty (78.4%) in LUS exam. Cohen's κ was run to determine if there was agreement between chest X-ray, 252 LUS and chest CT scan to show COVID-19 lung abnormal findings. There was a 253 strong agreement between chest CT and LUS (κ = 0.842; 95% CI 0.666 -1.000, p < 254 0.001). Chest X-ray did not show a statistical significant agreement with CT scan (κ = 255 0.205; p = 0.161). Whereas, LUS showed a weak correlation with chest X-ray (κ = 256 0.276; 95% CI 0.002 -0.550, p = 0.034). 257

Most of the patients showed a chest CT phenotype 1 (47.1%) and 2 (23.5%) 258 only 1 showed phenotype 3 (2%). An analysis of receiver operating characteristic 259 curves (Figure 4) showed that the area under the curve [AUC] for LUS score was 86.4% (95% CI, 76.7%-96.2%, p<0.001) to identify phenotype 2. The cut-off value 261 of LUS score of 9.5 had a S of 100% and Sp of 77.2% (p<0.001). 262

Although, there were three patients with LUS findings compatible of COVID-263 19, on CT two were informed as having a viral bronchiolitis and one had pulmonary 264 metastatic disease. 265

An analysis of receiver operating characteristic curves ( Figure 5) In our study, we found an excellent correlation between CT and LUS. All 274 abnormal CT findings were detected on LUS, therefore no abnormal CT findings 275 were labeled as normal on LUS. In other words, with this technic the proportion of 276 false negative rates will be really low, which in this pandemic is a key question, in 277 order to avoid additional infections. 278

There is growing literature regarding the diagnostic challenges (Shi et al. 2020 279 and Zhang et al. 2020) in COVID-19 patients. The positivity rate of RT-PCR has 280 been quantified as 63% in nasal swab and 32% in pharyngeal swab (Wang et al. 281 2020) , similar to our results, we found a positive rate of only 47.9%. Due to its 282 limitations, diagnostic imaging plays a key role in the management of these patients. 283

A study of 1049 patients undergoing chest CT scan and RT-PCR testing 284 determined that CT abnormalities had a highly sensitivity for diagnosis of COVID-19 285 patients (Ai et al. 2020) , suggesting that CT scan should be considered as a screening 286 tool, especially in epidemic areas with high pre-test probability. Therefore in many 287 centers CT scans have been replaced for chest X-ray. However, the use of CT scan in 288 the ED has many limitations, such as the radiation exposure, especially for mild 289 illness, the low availability and the contraindication of its use in unstable patients. 290

Also, we found a proportion of normal chest CT that is relatively high (27.4%), but 291 similar to those previously reported (30.8%) . 292

Preliminary reports in COVID-19 era, suggest there is a correlation of LUS 293 findings to those of the CT scan (Poggiali et al. 2020 and Peng et al. 2020) . These 294

reports have characterized LUS findings in COVID-19 patients. Moreover, Soldati et 295 al (2020) have proposed a standardized approach to performing LUS in these patients, 296

including a 14-zone technique, and a scoring system to quantify severity of lung 297 involvement. Although we agree there should be a consensus in the LUS exam 298 method, the 12-zone is more extended and validated (Cantinotti et al. 2020) . 299

There have been reports regarding the cardiac injury in COVID-19 patients 300 that ranges from 7.2%-14% . In our study, we found one young 301 patient that had a normal LUS exam, which prompted a sonographic focused 302 cardiovascular assessment, showing a left ventricular dysfunction and pericardial 303 effusion, allowing immediate therapy adjustment. His chest CT scan was 304

There were 2 patients with absence of typical findings for COVID-19 (central 306 distribution); one patient had acute bronchiolitis and the other patient a 307 decompensated heart failure episode. Both of them, although had mainly central 308 involvement on CT, had also some degree of peripheral involvement of the lungs, 309 which was seen on LUS, misidentifying as COVID-19 suspicious findings. This is 310 one of the main limitations of LUS (Volpicelli et al. 2012) , the low specificity, since 311 the findings might overlap with those from other lung disease etiologies, such as other 312 viral illnesses, pulmonary infarction or metastatic disease. Although, the same might 313 happen with CT scans, that can misidentify other viral pneumonias as However, in this pandemic, positive LUS or CT features, even in negative RT-PCR 315 can still be highly suggestive of COVID-19 infection. 316

There are several advantages of performing LUS over CT scan, particularly 317

for specific populations, such as pregnant women (Buonsenso 2020 and Inchingolo 318 2020) and children (De Rose 2020 and Musolino 2020), especially when performed 319 with portable handheld ultrasound devices, may provide an inexpensive, accessible, 320 portable, user-friendly, and easy-to-disinfect method for assessing progression of 321 cardiopulmonary pathology in patients with COVID-19 pneumonia. Moreover, avoids 322 having to transport a patient with suspected COVID-19 to radiology (exposing other 323 patients or health care providers). 324

In our study we found a high correlation between LUS findings and chest CT 325 abnormalities suggestive of lung involvement due to SARS-CoV-2 infection. As 326 previously reported , most of the patients had a predominance of 327 peripheral involvement of both lungs (92.5%, 37 out of 40 patients with abnormal CT 328 findings), which can be reached with ultrasound. Notably, the LUS score showed a 329 better correlation than CT TSS in demographic data (age), physical exam (respiratory 330 rate, SO2) and other established biomarkers (CRP) with proven utility in this setting, 331 this higher correlation should be interpreted cautiously, although might suggest that a 332 12-zone LUS Score, with the representation of posterior lobes in at least half of the 333 zones (in comparison to a 5 lobes division, where posterior lobes represent 2) could 334 better reflect the physiological state of the patient. 335

Chest CT features differ among patients, being possible to establish distinct 336 phenotypes that might guide therapy and ventilator settings (Robba et al 2020) . In 337 phenotype 1, a high pulmonary compliance and severe hypoxemia occurs, these 338 patients may benefit from use of low to moderate PEEP and are likely to respond well 339 to inhaled nitric oxide. In phenotype 2, moderate to high PEEP as well as prone 340 positioning may help recruit collapsed areas. Phenotype 3 resembles typical ARDS 341 and should be managed as such. In our study, we found that a cut-off Lung score of 342 9.5 had a high sensitivity and specificity for detecting phenotype 2. 343 Therefore this technique could be more easily replaced with LUS as it would 344 be more accessible during the pandemic, especially accelerated as Artificial 345

Intelligence algorithms to easy recognize COVID-19 related pathology and 346 telemedicine programs are developed. 347 -Strengths: 348

To our knowledge, this is the first study evaluating the correlation of LUS 349 with CT scan, with the diagnostic and prognostic implications. We evaluated the 350 radiologic burden (CT and LUS) with clinical manifestation, laboratory results and 351 outcomes. 352

There are several limitations to consider. The main limitation is that LUS in 354 general has a poor specificity, its findings overlap with those from other pneumonia etiologies or incidental chronic findings (e.g., chronic heart failure or pulmonary 356 fibrosis). In epidemic areas, however, positive LUS features, even with negative RT-357 PCR or chest X-ray, can still be highly suggestive of COVID-19 infection. Thus, the 358 results from this study provide an opportunity to further investigate the use of 359 ultrasound in various settings and clinical scenarios, when the prevalence it lowers. 360

Another limitation is that selection bias might have occurred. The expert 361 sonographer performed all ultrasound scans on a consecutive sample selected based 362 on his availability (during his working hours), which limits the generalizability of our 363

results. This was mitigated by the variable schedule and changing shifts, 364 unpredictable a priori (in continuous care). Additionally, false negative ultrasound or 365 CT might be found in the initial stage of the disease, before lung involvement, 366 consequently imaging techniques should be considered a complement to RT-PCR and 367 laboratory tests. 368

We did not correlate the LUS or CT findings with the patient's outcomes. 369

Moreover, the study was not powered to evaluate the performance of a diagnostic 370 strategy based on LUS exam; therefore, for this purpose, the study can only be 371 considered hypothesis generating. Thus, the results from this study open an 372 opportunity to further investigate the use of ultrasound in different settings and 373 clinical scenarios, especially in the follow-up. 374

We want to share our study findings, given the urgent need for different 375 strategies in order to better manage COVID-19 patients, and diminish the SARS-376

CoV-2 spread and its prognosis in the current pandemic context. As the shortage of 377 resources constitutes an undeniable public health threat, we consider LUS to be a 378 potential solution, and recommend that it should be performed as a first-line and 

Correlation 398 of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in 399 China: A Report of 1014 Cases

Point-of-Care and Clinical Ultrasound Guidelines in Medicine

Point-404 of-Care Lung Ultrasound findings in novel coronavirus disease-19 405 pnemoniae: a case report and potential applications during COVID-19 406 outbreak

COVID-19 outbreak: less stethoscope, more 408 ultrasound

Clinical role of lung 411 ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in 412 pregnant women

Prognostic Value of a New Lung Ultrasound Score to Predict Intensive Care Unit 416 Stay in Pediatric Cardiac Surgery

418 How to Perform Pediatric Lung Ultrasound Examinations in the Time of 419 COVID -19

Clinical Characteristics of Coronavirus Disease 2019 in 425 China

Clinical features of 429 patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

The Diagnosis of Pneumonia in a 433 Pregnant Woman with COVID-19 Using Maternal Lung Ultrasound

COUNTERPOINT: Should the Use of 438 Diagnostic Point-of-Care Ultarsound in Patient Care Require Hospital 439

Privileging/credentialing? No. Chest

CT 441 image visual quantitative evaluation and clinical classification of coronavirus 442 disease (COVID-19)

Disease-19 (COVID-19) by Bedside Ultrasound

on behalf of the ROMULUS 449 COVID Team. Lung Ultrasound in Children with COVID-19: Preliminary 450 Findings

Findings of lung ultrasonography of novel corona virus pneumonia 453 during the 2019-2020 epidemic

Can Lung US Help Critical 457

Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) 458 Pneumonia? Radiology

Distinct phenotypes require 461 distinct respiratory management strategies in severe COVID-19, Respiratory 462 Physiology and amp

Radiological 465 findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a 466 descriptive study

Proposal 469 for International Standardization of the Use of Lung Ultrasound for Patients With 470 COVID-19: A Simple, Quantitative, Reproducible Method

Is There a 474 Role for Lung Ultrasound During the COVID-19 Pandemic?: Clinical Letters

Ultrasound assessment of lung aeration loss during 478 a successful weaning trial predicts postextubation distress*: Crit Care Med

484 International Liaison Committee on Lung Ultrasound (ILC-LUS) for the 485 International Consensus Conference on Lung Ultrasound (ICC-LUS)

International evidence-based recommendations for point-of-care lung ultrasound. 487 Intensive Care Med

What's new in lung ultrasound during the 489 COVID-19 pandemic

POINT: Should the Use of Diagnostic 491 Point-of-Care Ultrasound in Patient Care Require Hospital 492

Detection of SARS-CoV-2 494 in Different Types of Clinical Specimens

CT 497 features of SARS-CoV-2 pneumonia according to clinical presentation: a 498 retrospective analysis of 120 consecutive patients from Wuhan city

DBP: diastolic blood pressure; IL-6: Interleukin 6; LDH: Lactate dehydrogenase; NT-ProBNP: N-terminal pro-brain natriuretic peptide

PCT: procalcitonin; RT-PCR: reverse transcriptase polymerase chain reaction; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; SBP: systolic blood pressure

Ground-Glass Opacity (GGO) -(%)